"The only sure rule in golf is he who has the fastest cart never has to play the bad lie.” – Mickey Mantle
Today, we take an in-depth look at a Busted IPO that recently retrenched and raised additional capital after abandoning a mid-stage trial. A full investment analysis follows below.
Company Overview:
Magenta Therapeutics, Inc. (MGTA) is a Cambridge, Massachusetts, based early clinical-stage biotechnology concern focused on the development of compounds that upgrade the current immune reset process in patients with blood cancers, as well as genetic and autoimmune diseases. It